Drug intelligence / Profile preview

N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide is an experimental small molecule compound featuring a piperidine ring conjugated to a benzyl group and a sulfanyl-substituted butanamide moiety. It is classified as a heterocyclic compound and has not been approved for any medical use. There are no known clinical trials or approved indications for this molecule, and its mechanism of action has not been characterized in the literature. The compound's structure suggests potential activity in central nervous system research due to its similarity to other piperidine derivatives, but no pharmacological or therapeutic data are available[1][2][3][4].

Other names
N-(1-Benzyl-4-piperidinyl)-4-sulfanylbutanamideButanamide, 4-mercapto-N-[1-(phenylmethyl)-4-piperidinyl]-N-(1-Benzylpiperidin-4-yl)-4-thiobutanamide
02

Targets

BACE1 (Beta-site APP-cleaving enzyme 1)

Beyond the preview

Go deeper on N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call